The impact of non-fasting state on clinical decision making in the identification of dyslipidemias is similar for both non-HDL-C and TG/HDL-C, although non-HDL-C better reveals abnormalities in lipid metabolism, covering all atherogenic particles containing ApoB [3]. The gene discussed is APOB; the disease is metabolic syndrome.